
Discovery Biosafety
Sep 8, 2014
Recent biosafety lapses in high-security labs, including the accidental exposure of workers to live anthrax and flu strains. Calls for reducing risky research and implementing stricter safety measures. Debate on the benefits versus risks of handling deadly pathogens and the need to eliminate human error in scientific work.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 5min
Safety Concerns and Incidents at the CDC and NIH Labs
04:35 • 2min
Navigating Biosafety Protocols in High-Security Labs
06:18 • 11min
Unveiling the Legacy of Smallpox
17:32 • 9min
Debate on Risk Assessment and Ethical Considerations in Genetic Engineering
26:07 • 2min
